Interviews

GE Healthcare expands its life sciences business

Peter Ehrenheim, President & CEO, Life Sciences, GE Healthcare
"Our current business focus and strengths are in the areas of bioprocessing, proteins, cellular analysis, cell handling and tools for cell therapy. Our strategic intent is to add adjacent technologies or applications which can add value to the overall customer solutions we provide. "

Clinical Trials

A Logistics Perspective

Lim Bee Koong, Director, Life Sciences - Clinical, TNT Asia
"Clinical trials have very detailed and precise processes and the logistical elements of these processes are critical. Recent revisions to the pharmaceutical industry’s regulatory laws as well as improved patent laws in countries such as Japan, China and India, have led to the burgeoning clinical trials market in Asia."

Emerging Opportunities in Asian Clinical Trials

Dr.Ken Ren, President, Accelovance China
"Asia has had a dramatic spike in interest for medical research, pharma advancement and global investment. China and India are emerging as leaders in clinical trials. They recruit patients faster, cheaper and are better than Europe, South America or the US because the economies are encouraging more research."

Growth of Generics Market in Asia

Laura Harris, Analyst, Pharmaceutical Research Unit, Datamonitor
"Key factors include the changing patent laws as countries aim to become more TRIPS compliant, with India updating its law recently and China in the process of doing so through the WTO. Increasing globalization of the generics market, with Indian companies becoming involved in Europe and the US and vice versa, will also provide an opportunity for generics."